跳至主要内容
临床试验/NCT00232492
NCT00232492已完成4 期

Effect of Racemic Ketamine on Pain in Females and Males After Surgical Removal of Third Molars

Ullevaal University Hospital1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
128
试验地点
1
主要终点
Sum pain NRS

研究概览

简要总结

The purpose of the study is to determine whether equal subanesthetic doses of racemic ketamine is equally effective on females and males after surgical removal of third molars

详细描述

Ketamine is assumed to be a NMDA receptor antagonist which provides analgesia from acute postoperative pain(and other types of pain) subanesthetic doses. Gender differences in ketamine analgesia are not known. This placebo-controlled,randomised, parallel group study investigates the analgesic dose-response effect of ketamine in subanesthetic doses in female and male patients following surgical removal of third molars.

Comparisons: Placebo and ketamine in females and males.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for removal of third molar
  • Between 20 and 30 years of age
  • ASA Class 1

排除标准

  • Psychiatric family (father/mother) or own anamnestic history
  • Hypersensitivity towards NSAIDS or other rescue analgesics
  • Verified or suspected pregnancy
  • Lactating females
  • Surgery lasting over 60 min

研究组 & 干预措施

Placebo males

Placebo Comparator

Saline physiological placebo males

干预措施: Placebo males (Drug)

Ketamine 0,1 mg/kg males

Active Comparator

0,1 mg/kg ketamine males

干预措施: Ketamine 0,1 mg/kg males (Drug)

Ketamine 0,3 mg/kg males

Active Comparator

0,3 mg/kg ketamine males

干预措施: Ketamine 0,3 mg/kg males (Drug)

Ketamine 0,5 mg/kg males

Active Comparator

0,5 mg/kg ketamine males

干预措施: Ketamine 0,5 mg/kg males (Drug)

Placebo females

Placebo Comparator

Saline physiological as placebo females

干预措施: Placebo females (Drug)

Ketamine 0.1 mg/kg females

Active Comparator

0,1 mg/kg ketamine females

干预措施: Ketamine 0,1 mg/kg females (Drug)

Ketamine 0,3 mg/kg females

Active Comparator

0,3 mg/kg ketamine females

干预措施: Ketamine 0,3 mg/kg females (Drug)

Ketamine 0,5 mg/kg females

Active Comparator

0,5 mg/kg ketamine females

干预措施: Ketamine 0,5 mg/kg females (Drug)

结局指标

主要结局

Sum pain NRS

时间窗: 60 min

次要结局

  • Several subjective variables assessing psychotomimetic effects(0, 15, 60)

研究者

发起方
Ullevaal University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验